Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Cariprazine in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have provided informed consent prior to any study specific procedures~* Patients currently meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for schizophrenia (paranoid type, disorganized type, catatonic type or undifferentiated type), as confirmed by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID)~* Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCIPANSS) total score ≥ 80 and ≤ 120~* Diagnosis of schizophrenia for a minimum of 1 year before Visit 1~* Patients with normal physical examination, laboratory, vital signs,and/ or electrocardiogram (ECG)~Exclusion Criteria:~* Patients with a DSM-IV-TR diagnosis of Schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder~* Patients in their first episode of psychosis~* Pregnant, breast-feeding, and/or planning to become pregnant and/or breastfeed during the study~* Pervasive developmental disorder, mental retardation, delirium, dementia, amnestic and other cognitive disorders~* Known or suspected borderline or antisocial personality disorder or other DSM-IV-TR axis II disorder of sufficient severity to interfere with participation in this study~* Substance abuse or dependence within the prior 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Cariprazine (3-6 mg/day) (Type: EXPERIMENTAL): Cariprazine once daily fixed-flexible low dose
- Cariprazine (6-9 mg/day) (Type: EXPERIMENTAL): Cariprazine once daily fixed-flexible high dose
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).